lobbying_activities: 3332630

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3332630	a0d87146-33cd-41af-a538-5dfca5aa5b0d	Q1	GOVERNMENT COUNSEL, LLC	401105070	APOTEX CORPORATION	2025	first_quarter	MAN	Federal policy relating to trade tariffs, strengthening domestic generic production and market access barriers for generic pharmaceuticals.	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2025-04-13T13:39:01-04:00